Cargando…
Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
BACKGROUND: Transferrin receptor 1 (TfR1) mediated brain delivery of antibodies could become important for increasing the efficacy of emerging immunotherapies in Alzheimer's disease (AD). However, age, dose, binding to TfR1 on blood cells, and pathology could influence the TfR1-mediated transcy...
Autores principales: | Faresjö, Rebecca, Sehlin, Dag, Syvänen, Stina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173660/ https://www.ncbi.nlm.nih.gov/pubmed/37170266 http://dx.doi.org/10.1186/s12987-023-00435-2 |
Ejemplares similares
-
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
por: Bien-Ly, Nga, et al.
Publicado: (2014) -
Regulation of mitochondrial morphology and function by Stearoylation of TfR1
por: Senyilmaz, Deniz, et al.
Publicado: (2015) -
Rational design of universal immunotherapy for TfR1-tropic arenaviruses
por: Cohen-Dvashi, Hadas, et al.
Publicado: (2020) -
Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents
por: Candelaria, Pierre V., et al.
Publicado: (2021) -
TfR1 interacts with the IKK complex and is involved in IKK–NF-κB signalling
por: Kenneth, Niall S., et al.
Publicado: (2012)